Hortobagyi G - Search Results

1

The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.

Morandi P, Rouzier R, Altundag K, Buzdar AU, Theriault RL, Hortobagyi G. Morandi P, et al. Among authors: hortobagyi g. Cancer. 2004 Oct 1;101(7):1482-9. doi: 10.1002/cncr.20522. Cancer. 2004. PMID: 15378476 Free article. Review.

2

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.

Assikis V, Buzdar A, Yang Y, Smith T, Theriault R, Booser D, Valero V, Walters R, Singletary E, Ames F, Hortobagyi G. Assikis V, et al. Among authors: hortobagyi g. Cancer. 2003 Jun 1;97(11):2716-23. doi: 10.1002/cncr.11396. Cancer. 2003. PMID: 12767083 Free article. Clinical Trial.

3

Update on endocrine therapy for breast cancer.

Buzdar AU, Hortobagyi G. Buzdar AU, et al. Among authors: hortobagyi g. Clin Cancer Res. 1998 Mar;4(3):527-34. Clin Cancer Res. 1998. PMID: 9533518 Review.

4

Development of new cancers in patients with DCIS: the M.D. Anderson experience.

Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Yang W, Albarracin C, Meric F, Hortobagyi G, Theriault R. Dawood S, et al. Among authors: hortobagyi g. Ann Surg Oncol. 2008 Jan;15(1):244-9. doi: 10.1245/s10434-007-9661-8. Epub 2007 Nov 28. Ann Surg Oncol. 2008. PMID: 18043978

5

A unified definition of clinical anthracycline resistance breast cancer.

Pivot X, Asmar L, Buzdar AU, Valero V, Hortobagyi G. Pivot X, et al. Among authors: hortobagyi g. Br J Cancer. 2000 Feb;82(3):529-34. doi: 10.1054/bjoc.1999.0958. Br J Cancer. 2000. PMID: 10682660 Free PMC article.

6

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.

Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Katz A, et al. Among authors: hortobagyi g. J Clin Oncol. 2000 Aug;18(15):2817-27. doi: 10.1200/JCO.2000.18.15.2817. J Clin Oncol. 2000. PMID: 10920129

7

Phase II evaluation of Ly156758 in metastatic breast cancer.

Buzdar AU, Marcus C, Holmes F, Hug V, Hortobagyi G. Buzdar AU, et al. Among authors: hortobagyi g. Oncology. 1988;45(5):344-5. doi: 10.1159/000226637. Oncology. 1988. PMID: 3412740

8

Inflammatory breast cancer: a review.

Jaiyesimi IA, Buzdar AU, Hortobagyi G. Jaiyesimi IA, et al. Among authors: hortobagyi g. J Clin Oncol. 1992 Jun;10(6):1014-24. doi: 10.1200/JCO.1992.10.6.1014. J Clin Oncol. 1992. PMID: 1588366 Review.

9

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Among authors: hortobagyi g. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

10

Vertebral osteomyelitis mimicking bone metastasis in breast cancer patients.

Voravud N, Theriault R, Hortobagyi G. Voravud N, et al. Among authors: hortobagyi g. Am J Clin Oncol. 1992 Oct;15(5):428-32. doi: 10.1097/00000421-199210000-00006. Am J Clin Oncol. 1992. PMID: 1524044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,209 results

Search Page

Filters